new drugs often marketed ahead of crucial data
data that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market, according to u.s. researchers.
http://feeds.reuters.com/~r/reuters/healthnews/~3/qn9stlj5qze/us-drugs-data-idustre7437vg20110504
30869
05 May 2011 00:43:30
reuters
health